4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-23-034605
CFO and CBO sold 1,960 shares at $11.41 ($22,368)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Henderson Molly CFO and CBO | 2023-06-02 | Sale 10b5-1 | −1,960 | $11.41 | $22,368 | 68,506 | D |
| Open-market sales · 1,960 sh · avg $11.41 · $22,368 | |||||||
Loading xslF345X04/doc4.xml…